Fibrils colocalize caspase-3 with procaspase-3 to foster maturation

Journal of Biological Chemistry

Volumn 287, Issue 40, 2012, Pages 33781-33795

  Zorn, Julie A ^a   Wolan, Dennis W ^a,c   Agard, Nicholas J ^a,d   Wells, James A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d R and D Project Development and Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MECHANISMS; CASPASE-3; CELLULAR SIGNALING; COLOCALIZATION; COLOCALIZE; IN-VITRO; LIMITED PROTEOLYSIS; NANO-FIBRILS; SELF-ACTIVATION; SMALL MOLECULES; TRACE AMOUNTS;

BIOCHEMISTRY; BIOLOGY;

CELL DEATH;

AMYLOID BETA PROTEIN[1-40]; CASPASE 3; ENZYME PRECURSOR; PROCASPASE 3; PROTEINASE;

APOPTOSIS; ARTICLE; BIOCHEMISTRY; CELL FATE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PURIFICATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

AMYLOID BETA-PEPTIDES; APOPTOSIS; CASPASE 3; CATALYSIS; DIMERIZATION; DRUG DELIVERY SYSTEMS; ENZYME ACTIVATION; ENZYME PRECURSORS; HUMANS; KINETICS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PEPTIDE HYDROLASES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84866931834     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.386128     Document Type: Article

References (86)

1. Turk, B. (2006) Targeting proteases. Successes, failures, and future prospects. Nat. Rev. Drug Discov. 5, 785-799
2. Khan, A. R., and James, M. N. (1998) Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci. 7, 815-836 (Pubitemid 28216525)
3. Stroud, R. M., Kossiakoff, A. A., and Chambers, J. L. (1977) Mechanisms of zymogen activation. Annu. Rev. Biophys. Bioeng. 6, 177-193
4. Shen, A. (2010) Allosteric regulation of protease activity by small molecules. Mol. Biosyst. 6, 1431-1443
5. Donepudi, M., and Grütter, M. G. (2002) Structure and zymogen activation of caspases. Biophys. Chem. 101, 145-153 (Pubitemid 35462043)
6. Stennicke, H. R., and Salvesen, G. S. (2000) Caspases. Controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta 1477, 299-306 (Pubitemid 30119908)
7. Gray, D. C., Mahrus, S., and Wells, J. A. (2010) Activation of specific apoptotic caspases with an engineered small molecule-activated protease. Cell 142, 637-646
8. Salvesen, G. S., and Riedl, S. J. (2008) Caspase mechanisms. Adv. Exp. Med. Biol. 615, 13-23
9. Li, J., and Yuan, J. (2008) Caspases in apoptosis and beyond. Oncogene 27, 6194-6206
10. Yuan, S., Yu, X., Asara, J. M., Heuser, J. E., Ludtke, S. J., and Akey, C. W. (2011) The Holo-apoptosome. Activation of procaspase-9 and interactions with caspase-3. Structure 19, 1084-1096
11. Renatus, M., Stennicke, H. R., Scott, F. L., Liddington, R. C., and Salvesen, G. S. (2001) Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. U.S.A. 98, 14250-14255 (Pubitemid 33121378)
12. Donepudi, M., Mac Sweeney, A., Briand, C., and Grütter, M. G. (2003) Insights into the regulatory mechanism for caspase-8 activation. Mol. Cell 11, 543-549 (Pubitemid 36297058)
13. Yang, X., Chang, H. Y., and Baltimore, D. (1998) Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell 1, 319-325 (Pubitemid 128378672)
14. Twiddy, D., Cohen, G. M., Macfarlane, M., and Cain, K. (2006) Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex. J. Biol. Chem. 281, 3876-3888 (Pubitemid 43847811)
15. Yin, Q., Park, H. H., Chung, J. Y., Lin, S. C., Lo, Y. C., da Graca, L. S., Jiang, X., and Wu, H. (2006) Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine. Mol. Cell 22, 259-268
16. Muzio, M., Salvesen, G. S., and Dixit, V. M. (1997) FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J. Biol. Chem. 272, 2952-2956 (Pubitemid 27053346)
17. Mahrus, S., Trinidad, J. C., Barkan, D. T., Sali, A., Burlingame, A. L., and Wells, J. A. (2008) Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134, 866-876
18. Dix, M. M., Simon, G. M., and Cravatt, B. F. (2008) Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134, 679-691
19. Lüthi, A. U., and Martin, S. J. (2007) The CASBAH. A searchable database of caspase substrates. Cell Death Differ. 14, 641-650 (Pubitemid 46444502)
20. Putt, K. S., Chen, G. W., Pearson, J. M., Sandhorst, J. S., Hoagland, M. S., Kwon, J. T., Hwang, S. K., Jin, H., Churchwell, M. I., Cho, M. H., Doerge, D. R., Helferich, W. G., and Hergenrother, P. J. (2006) Small molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat. Chem. Biol. 2, 543-550 (Pubitemid 44413237)
21. Schipper, J. L., MacKenzie, S. H., Sharma, A., and Clark, A. C. (2011) A bifunctional allosteric site in the dimer interface of procaspase-3. Biophys. Chem. 159, 100-109
22. Wolan, D. W., Zorn, J. A., Gray, D. C., and Wells, J. A. (2009) Small molecule activators of a proenzyme. Science 326, 853-858
23. Zorn, J. A., Wille, H., Wolan, D. W., and Wells, J. A. (2011) Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation. J. Am. Chem. Soc. 133, 19630-19633
24. Nikolaev, A., McLaughlin, T., O'Leary, D. D., and Tessier-Lavigne, M. (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981-989
25. Wellington, C. L., Ellerby, L. M., Gutekunst, C. A., Rogers, D., Warby, S., Graham, R. K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y. Z., Gafni, J., Bredesen, D., Hersch, S. M., Leavitt, B. R., Roy, S., Nicholson, D. W., and Hayden, M. R. (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington disease. J. Neurosci. 22, 7862-7872 (Pubitemid 35379091)
26. Hermel, E., Gafni, J., Propp, S. S., Leavitt, B. R., Wellington, C. L., Young, J. E., Hackam, A. S., Logvinova, A. V., Peel, A. L., Chen, S. F., Hook, V., Singaraja, R., Krajewski, S., Goldsmith, P. C., Ellerby, H. M., Hayden, M. R., Bredesen, D. E., and Ellerby, L. M. (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington disease. Cell Death Differ. 11, 424-438 (Pubitemid 38489420)
27. Wellington, C. L., and Hayden, M. R. (2000) Caspases and neurodegeneration. On the cutting edge of new therapeutic approaches. Clin. Genet. 57, 1-10 (Pubitemid 30105555)
28. Umeda, T., Tomiyama, T., Sakama, N., Tanaka, S., Lambert, M. P., Klein, W. L., and Mori, H. (2011) Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. J. Neurosci. Res. 89, 1031-1042
29. Frost, B., and Diamond, M. I. (2010) Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155-159
30. Graham, R. K., Ehrnhoefer, D. E., and Hayden, M. R. (2011) Caspase-6 and neurodegeneration. Trends Neurosci. 34, 646-656
31. Lee, J. C., Schickling, O., Stegh, A. H., Oshima, R. G., Dinsdale, D., Cohen, G. M., and Peter, M. E. (2002) DEDD regulates degradation of intermediate filaments during apoptosis. J. Cell Biol. 158, 1051-1066
32. Dinsdale, D., Lee, J. C., Dewson, G., Cohen, G. M., and Peter, M. E. (2004) Intermediate filaments control the intracellular distribution of caspases during apoptosis. Am. J. Pathol. 164, 395-407 (Pubitemid 38364656)
33. Peterson, Q. P., Goode, D. R., West, D. C., Ramsey, K. N., Lee, J. J., and Hergenrother, P. J. (2009) PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition. J. Mol. Biol. 388, 144-158
34. Roy, S., Bayly, C. I., Gareau, Y., Houtzager, V. M., Kargman, S., Keen, S. L., Rowland, K., Seiden, I. M., Thornberry, N. A., and Nicholson, D. W. (2001) Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide. Proc. Natl. Acad. Sci. U.S.A. 98, 6132-6137 (Pubitemid 32488205)
35. Colussi, P. A., Harvey, N. L., Shearwin-Whyatt, L. M., and Kumar, S. (1998) Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J. Biol. Chem. 273, 26566-26570 (Pubitemid 28471667)
36. Denault, J. B., and Salvesen, G. S. (2003) Expression, purification, and characterization of caspases. Curr. Protoc. Protein Sci. Chapter 21, Unit 21.13
37. Stennicke, H. R., and Salvesen, G. S. (1997) Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem. 272, 25719-25723 (Pubitemid 27438890)
38. Stennicke, H. R., and Salvesen, G. S. (1998) Properties of the caspases. Biochim. Biophys. Acta 1387, 17-31 (Pubitemid 28529204)
39. Stennicke, H. R., and Salvesen, G. S. (1999) Catalytic properties of the caspases. Cell Death Differ. 6, 1054-1059
40. Pop, C., Timmer, J., Sperandio, S., and Salvesen, G. S. (2006) The apoptosome activates caspase-9 by dimerization. Mol. Cell 22, 269-275
41. Graybill, T. L., Dolle, R. E., Helaszek, C. T., Ator, M. A., and Strasters, J. (1995) Synthesis and evaluation of diacylhydrazines as inhibitors of the interleukin-1β-converting enzyme (ICE). Bioorg. Med. Chem. Lett. 5, 1197-1202
42. Coan, K. E., and Shoichet, B. K. (2008) Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. J. Am. Chem. Soc. 130, 9606-9612 (Pubitemid 352031174)
43. Park, C., and Marqusee, S. (2005) Pulse proteolysis. A simple method for quantitative determination of protein stability and ligand binding. Nat. Methods 2, 207-212 (Pubitemid 41122128)
44. Timmer, J. C., Zhu, W., Pop, C., Regan, T., Snipas, S. J., Eroshkin, A. M., Riedl, S. J., and Salvesen, G. S. (2009) Structural and kinetic determinants of protease substrates. Nat. Struct. Mol. Biol. 16, 1101-1108
45. Pop, C., Salvesen, G. S., and Scott, F. L. (2008) Caspase assays. Identifying caspase activity and substrates in vitro and in vivo. Methods Enzymol. 446, 351-367
46. Smith, T. J., Stains, C. I., Meyer, S. C., and Ghosh, I. (2006) Inhibition of β-amyloid fibrillization by directed evolution of a β-sheet presenting miniature protein. J. Am. Chem. Soc. 128, 14456-14457 (Pubitemid 44749835)
47. Wu, J. W., Wu, Y., and Wang, Z. X. (2001) Kinetic analysis of a simplified scheme of autocatalytic zymogen activation. Eur. J. Biochem. 268, 1547-1553 (Pubitemid 32862686)
48. Kassell, B., and Kay, J. (1973) Zymogens of proteolytic enzymes. Science 180, 1022-1027
49. Park, C., and Marqusee, S. (2006) Quantitative determination of protein stability and ligand binding by pulse proteolysis. Curr. Protoc. Protein Sci. Chapter 20, Unit 20.11
50. Pop, C., Chen, Y. R., Smith, B., Bose, K., Bobay, B., Tripathy, A., Franzen, S., and Clark, A. C. (2001) Removal of the prodomain does not affect the conformation of the procaspase-3 dimer. Biochemistry 40, 14224-14235 (Pubitemid 33081626)
51. Svingen, P. A., Loegering, D., Rodriquez, J., Meng, X. W., Mesner, P. W., Jr., Holbeck, S., Monks, A., Krajewski, S., Scudiero, D. A., Sausville, E. A., Reed, J. C., Lazebnik, Y. A., and Kaufmann, S. H. (2004) Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel. Clin. Cancer Res. 10, 6807-6820 (Pubitemid 39383029)
52. Pop, C., Feeney, B., Tripathy, A., and Clark, A. C. (2003) Mutations in the procaspase-3 dimer interface affect the activity of the zymogen. Biochemistry 42, 12311-12320 (Pubitemid 37296507)
53. Ganesan, R., Mittl, P. R., Jelakovic, S., and Grütter, M. G. (2006) Extended substrate recognition in caspase-3 revealed by high resolution x-ray structure analysis. J. Mol. Biol. 359, 1378-1388 (Pubitemid 43922445)
54. Karki, P., Lee, J., Shin, S. Y., Cho, B., and Park, I. S. (2005) Kinetic comparison of procaspase-3 and caspase-3. Arch. Biochem. Biophys. 442, 125-132 (Pubitemid 41330998)
55. Zhou, Q., and Salvesen, G. S. (1997) Activation of procaspase-7 by serine proteases includes a noncanonical specificity. Biochem. J. 324, 361-364 (Pubitemid 27267975)
56. Denault, J. B., Békés, M., Scott, F. L., Sexton, K. M., Bogyo, M., and Salvesen, G. S. (2006) Engineered hybrid dimers. Tracking the activation pathway of caspase-7. Mol. Cell 23, 523-533 (Pubitemid 44205487)
57. Berger, A. B., Witte, M. D., Denault, J. B., Sadaghiani, A. M., Sexton, K. M., Salvesen, G. S., and Bogyo, M. (2006) Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol. Cell 23, 509-521 (Pubitemid 44205485)
58. Salvesen, G. S., and Dixit, V. M. (1999) Caspase activation. The induced-proximity model. Proc. Natl. Acad. Sci. U.S.A. 96, 10964-10967
59. Lee, J., Culyba, E. K., Powers, E. T., and Kelly, J. W. (2011) Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Nat. Chem. Biol. 7, 602-609
60. Stine, W. B., Jungbauer, L., Yu, C., and LaDu, M. J. (2011) Preparing synthetic Aβ in different aggregation states. Methods Mol. Biol. 670, 13-32
61. Schroder, K., and Tschopp, J. (2010) The inflammasomes. Cell 140, 821-832
62. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., and Alnemri, E. S. (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1, 949-957 (Pubitemid 128379256)
63. Yuan, R. T., Young, S., Liang, J., Schmid, M. C., Mielgo, A., and Stupack, D. G. (2012) Caspase-8 isoform 6 promotes death effector filament formation independent of microtubules. Apoptosis 17, 229-235
64. Siegel, R. M., Martin, D. A., Zheng, L., Ng, S. Y., Bertin, J., Cohen, J., and Lenardo, M. J. (1998) Death-effector filaments. Novel cytoplasmic structures that recruit caspases and trigger apoptosis. J. Cell Biol. 141, 1243-1253 (Pubitemid 28265617)
65. Bucciantini, M., Calloni, G., Chiti, F., Formigli, L., Nosi, D., Dobson, C. M., and Stefani, M. (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 279, 31374-31382 (Pubitemid 39037804)
66. Kranenburg, O., Bouma, B., Kroon-Batenburg, L. M., Reijerkerk, A., Wu, Y. P., Voest, E. E., and Gebbink, M. F. (2002) Tissue-type plasminogen activator is a multiligand cross-β structure receptor. Curr. Biol. 12, 1833-1839 (Pubitemid 35273903)
67. Kingston, I. B., Castro, M. J., and Anderson, S. (1995) In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues. Nat. Med. 1, 138-142
68. Tachias, K., and Madison, E. L. (1996) Converting tissue-type plasminogen activator into a zymogen. J. Biol. Chem. 271, 28749-28752 (Pubitemid 26382568)
69. Boose, J. A., Kuismanen, E., Gerard, R., Sambrook, J., and Gething, M. J. (1989) The single-chain form of tissue-type plasminogen activator has catalytic activity. Studies with a mutant enzyme that lacks the cleavage site. Biochemistry 28, 635-643 (Pubitemid 19047101)
70. Tate, K. M., Higgins, D. L., Holmes, W. E., Winkler, M. E., Heyneker, H. L., and Vehar, G. A. (1987) Functional role of proteolytic cleavage at arginine 275 of human tissue plasminogen activator as assessed by site-directed mutagenesis. Biochemistry 26, 338-343 (Pubitemid 17022102)
71. Madison, E. L., Kobe, A., Gething, M. J., Sambrook, J. F., and Goldsmith, E. J. (1993) Converting tissue plasminogen activator to a zymogen. A regulatory triad of Asp-His-Ser. Science 262, 419-421 (Pubitemid 23353383)
72. Madison, E. L., and Sambrook, J. E. (1993) Probing structure-function relationships of tissue-type plasminogen activator by oligonucleotide-mediated site-specific mutagenesis. Methods Enzymol. 223, 249-271
73. Robinson, N. C., Neurath, H., and Walsh, K. A. (1973) The relation of the -amino group of trypsin to enzyme function and zymogen activation. Biochemistry 12, 420-426
74. Gertler, A., Walsh, K. A., and Neurath, H. (1974) Catalysis by chymotrypsinogen. Demonstration of an acyl-zymogen intermediate. Biochemistry 13, 1302-1310
75. Silverberg, M., and Kaplan, A. P. (1982) Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII). Blood 60, 64-70 (Pubitemid 12085921)
76. Neurath, H., and Walsh, K. A. (1976) Role of proteolytic enzymes in biological regulation (a review). Proc. Natl. Acad. Sci. U.S.A. 73, 3825-3832
77. Lonsdale-Eccles, J. D., Neurath, H., and Walsh, K. A. (1978) Probes of the mechanism of zymogen catalysis. Biochemistry 17, 2805-2809 (Pubitemid 8385281)
78. Kay, J., and Kassell, B. (1971) The autoactivation of trypsinogen. J. Biol. Chem. 246, 6661-6665
79. Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., and Dixit, V. M. (1998) An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926-2930 (Pubitemid 28133943)
80. Lupardus, P. J., Shen, A., Bogyo, M., and Garcia, K. C. (2008) Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science 322, 265-268
81. Hardy, J. A., Lam, J., Nguyen, J. T., O'Brien, T., and Wells, J. A. (2004) Discovery of an allosteric site in the caspases. Proc. Natl. Acad. Sci. U.S.A. 101, 12461-12466 (Pubitemid 39122046)
82. Scheer, J. M., Romanowski, M. J., and Wells, J. A. (2006) A common allosteric site and mechanism in caspases. Proc. Natl. Acad. Sci. U.S.A. 103, 7595-7600
83. MacCorkle, R. A., Freeman, K. W., and Spencer, D. M. (1998) Synthetic activation of caspases. Artificial death switches. Proc. Natl. Acad. Sci. U.S.A. 95, 3655-3660 (Pubitemid 28173183)
84. Tse, E., and Rabbitts, T. H. (2000) Intracellular antibody caspase-mediated cell killing. An approach for application in cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 97, 12266-12271
85. Oberst, A., Pop, C., Tremblay, A. G., Blais, V., Denault, J. B., Salvesen, G. S., and Green, D. R.(2010) Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J. Biol. Chem. 285, 16632-16642
86. Chang, D. W., Xing, Z., Capacio, V. L., Peter, M. E., and Yang, X. (2003) Interdimer processing mechanism of procaspase-8 activation. EMBO J. 22, 4132-4142 (Pubitemid 37021742)